Jacob J Adashek

36PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Mar 06, 2025
Tumour-agnostic kinase inhibitors.

Jacob J Adashek, Mina Nikanjam, Razelle Kurzrock

|Jan 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.

Jia Liu, Max Farrow, Lesley Seymour

|Sep 10, 2024
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia.

Jacob J Adashek, Max Brodsky, Mark J Levis

|Feb 18, 2024
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.

Jacob J Adashek, Chinmayi Pandya, Nicholas J Maragakis

|Dec 22, 2023
Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity.

Jungah Lim, Razelle Kurzrock, Daisuke Nishizaki

|Dec 15, 2023
Considering molecular alterations as pan-cancer tissue-agnostic targets.

Jacob J Adashek, Shumei Kato, Jason K Sicklick

Pageof 6

Frequent Collaborators

16 joint publications

Razelle Kurzrock

7 joint publications

Vivek Subbiah

3 joint publications

Jason Roszik

3 joint publications

Shumei Kato